Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer

SIMPLE SUMMARY: Cancer treatments have significantly changed with the introduction of immunotherapy. Recently, the development of new agents that harness the redirection of T-cells against cancer is rapidly emerging in multiple tumor types. Since bispecific T-cell engager (BiTE) therapies have demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Simão, Diana C., Zarrabi, Kevin K., Mendes, José L., Luz, Ricardo, Garcia, Jorge A., Kelly, William K., Barata, Pedro C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001031/
https://www.ncbi.nlm.nih.gov/pubmed/36900202
http://dx.doi.org/10.3390/cancers15051412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001031/
https://www.ncbi.nlm.nih.gov/pubmed/36900202
http://dx.doi.org/10.3390/cancers15051412

Ejemplares similares